

The PLUSS Trial
175 posts

@PlussTrial
Intratracheal budesonide + surfactant to ⬆️ survival free of BPD in extremely preterm infants | @nhmrc @MCRI_for_kids @chiesigroup @thrasherfund



In extremely preterm infants, intratracheal budesonide mixed with surfactant did not reduce bronchopulmonary dysplasia or death by 36 weeks' postmenstrual age. ja.ma/3Kt2w1N

Wow what an International Clinical Trials Day for the @PlussTrial!! The @PlussTrial was awarded the @ACTA_org Clinical Trial of the Year, and the STInG Excellence in Statistics Award, presented to Kate Francis from @MCRI_for_kids #neotwitter @IMPACT_PSANZ @UniMelbMDHS @nhmrc















Today the results of the @PlussTrial were published in @JAMA_current! Intratracheal budesonide mixed with surfactant to increase survival free of BPD in extremely preterm infants born <28 weeks’ gestation jamanetwork.com/journals/jama/… A thread 🧵 (1/X) #neotwitter


The @PlussTrial was published today:




